2015
DOI: 10.1016/j.respe.2015.06.005
|View full text |Cite
|
Sign up to set email alerts
|

Use of health care reimbursement data to estimate vaccination coverage in France: Example of hepatitis B, meningitis C, and human papillomavirus vaccination

Abstract: This novel routine vaccination coverage monitoring tool provides regularly updated reactive and reliable vaccination coverage estimates in children.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
2
0
3

Year Published

2017
2017
2022
2022

Publication Types

Select...
8

Relationship

1
7

Authors

Journals

citations
Cited by 12 publications
(5 citation statements)
references
References 9 publications
0
2
0
3
Order By: Relevance
“…Le potentiel du PMSI (fiabilité et moindre coût) pour la surveillance et l'évaluation de maladies infectieuses a été démontré [17,51,60,63]. Les systèmes de surveillance des infections associées aux soins exposent la nécessité de développer de nouveaux outils pour une surveillance plus efficiente dans une conjecture économique contrainte [13,15,47,51,53]. Ainsi, les réseaux de surveillance des maladies infectieuses existants se renforcent et recherchent des indicateurs plus performants issus des BDMA [14,51,52,58,60].…”
Section: Discussionunclassified
See 2 more Smart Citations
“…Le potentiel du PMSI (fiabilité et moindre coût) pour la surveillance et l'évaluation de maladies infectieuses a été démontré [17,51,60,63]. Les systèmes de surveillance des infections associées aux soins exposent la nécessité de développer de nouveaux outils pour une surveillance plus efficiente dans une conjecture économique contrainte [13,15,47,51,53]. Ainsi, les réseaux de surveillance des maladies infectieuses existants se renforcent et recherchent des indicateurs plus performants issus des BDMA [14,51,52,58,60].…”
Section: Discussionunclassified
“…La couverture vaccinale, avec 11 publications, était le sujet le plus étudié [39][40][41][42][43][44][45][46][47][48][49]. Ces études avaient pour objectif d'estimer le taux de couverture vaccinale (rougeole, hépatite B, papillomavirus, méningocoque C, grippe) ou d'évaluer l'impact budgétaire de la vaccination contre les infections à papillomavirus humains (HPV) [41].…”
Section: Thématiques éTudiéesunclassified
See 1 more Smart Citation
“…Estimates of coverage for these antigens cannot be generated through the National Social Security Reimbursement Database because we excluded from the analysis all children in their first year of life with no reimbursement of any DTP-containing vaccine. This was to account for the very low percentage of children (estimated ca 5%) who benefit from free vaccination in the Maternal and Child Health clinics [11]. To estimate the coverage for hepatitis B, we computed the proportion of children vaccinated with a hexavalent vaccine with, as a denominator, the number of children receiving either a pentavalent or an hexavalent vaccine and multiplied this figure by the proportion of children receiving a DTP-containing vaccine, obtained by the analysis of the 24 months health certificates (99%), to account for children who do not receive any vaccine.…”
Section: Vaccination Coverage For Children Concerned By the Vaccinatimentioning
confidence: 99%
“…They have been described as both over- and underestimating vaccine coverage due to recall bias and incomplete records [6,7]. For some administrative data sources, such as reimbursement or insurance data, a clear denominator, the number of persons eligible for vaccination, is lacking [8,9]. In an effort to overcome such limitations, data sources have been merged.…”
Section: Introductionmentioning
confidence: 99%